Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T17:47:32.508Z.
Calculation as of: 2026-10-06T17:47:32.508Z.
Quote observation: 2026-10-06T17:40:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a49bf55b95e7accb53c24ef9933cb867312288378507dab28e57e4bc75072383
EARNINGS YIELD
N/A
Market Cap
$27.21M
Earnings Yield
N/A
TTM Avg
5.54%
3Y Avg
5.54%
5Y Avg
5.54%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InspireMD, Inc. (NSPR) | $25.76M | N/A | N/A | N/A | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $25.29M | N/A | N/A | N/A | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.54M | N/A | N/A | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.21M | N/A | 5.54% | 5.54% | 5.54% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.18M | N/A | 0.06% | 0.06% | 0.06% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.05M | N/A | 0.04% | 0.04% | 0.04% |
| aTyr Pharma, Inc. (ATYR)vs › | $27.57M | N/A | N/A | N/A | N/A |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.61M | N/A | 1.20% | 1.20% | 1.20% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.97M | N/A | N/A | N/A | N/A |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $28.86M | N/A | 0.41% | 0.41% | 0.41% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
